Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Re Kevetrin and p53 therapies: 12/31/15 article see online Cancer Cell lead author Eisenberg. They see aggregation of mutated p53 as one problem in cancer development. Specifically, working on ovarian CA they designed an agent to block p53 clumping, called ReACp53, that restores function of p53 in tumor cells.

They suggest it has some links to blocking clumping found in Alzheimer's and Parkinsons, for example.

Hard to know where it might be headed- certainly Kevetrin has a huge head start, and many more modes of action on p53.

It is just interesting to read about.